The human leucocyte antigen-G 14-basepair polymorphism correlates with graft-versus-host disease in unrelated bone marrow transplantation for thalassaemia

被引：44
作者：
La Nasa, Giorgio
Littera, Roberto
Locatelli, Franco
Lai, Sara
Alba, Francesco
Caocci, Giovanni
Lisini, Daniela
Nesci, Sonia
Vacca, Adriana
Piras, Eugenia
Bernardo, Maria Ester
Cesare-Merlone, Alessandra Di
Orru, Sandro
Carcassi, Carlo
机构：
[1] Univ Cagliari, Cattedra Genet Med, Osped R Binaghi, Dipartimento Sci Med Internist, I-09126 Cagliari, Italy
[2] Univ Cagliari, Dipartimento Sci Mediche Internistiche, Osped R Binaghi, Ctr Trapianti Midollo Osseo,Cattedra Ematol, Cagliari, Italy
[3] Osped R Binaghi, Ctr Res Trapianti, Cagliari, Italy
[4] Univ Pavia, Policlin San Matteo, Fonaz IRCCS, I-27100 Pavia, Italy
[5] Osped S Salvatore, Ctr Trapianti Midollo Osseo Muraglia, Unita Operat Ematol, Pesaro, Italy
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2007年 / 139卷 / 02期
关键词：
human leucocyte antigen-G; 14-basepair polymorphism; acute graft-versus-host disease; thalassaemia; bone marrow transplantation;
D O I：
10.1111/j.1365-2141.2007.06779.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The presence of the 14-bp insertion polymorphism of the human leucocyte antigen (HLA)-G gene (HLA-G) promotes immune tolerance through increased synthesis of HLA-G molecules. We investigated this polymorphism in a large cohort of 53 thalassaemia patients transplanted from an unrelated donor. Sixteen patients (30.2%) homozygous for the 14-bp deletion had a higher risk of developing acute graft-versus-host disease (aGvHD) than patients homozygous for the 14-bp insertion (-14-bp/-14-bp vs +14-bp/+14-bp: Relative Risk = 15.0; 95% confidence interval 1.59-141.24; P = 0.008). Therefore, the 14-bp polymorphism could be an important predictive factor for aGvHD following bone marrow transplantation.
引用
收藏
页码：284 / 288
页数：5
相关论文
共 50 条
  • [31] The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children
    A Rovelli
    C Arrigo
    F Nesi
    A Balduzzi
    B Nicolini
    A Locasciulli
    E Vassallo
    R Miniero
    C Uderzo
    Bone Marrow Transplantation, 1998, 21 : 577 - 581
  • [32] Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis
    RL Paquette
    L Tran
    EM Landaw
    Bone Marrow Transplantation, 1998, 22 : 351 - 357
  • [33] Organ tolerance following cadaveric liver transplantation for chronic graft-versus-host disease after allogeneic bone marrow transplantation
    Urban, C
    Deutschmann, A
    Kerbl, R
    Lackner, H
    Schwinger, W
    Königsrainer, A
    Margreiter, R
    BONE MARROW TRANSPLANTATION, 2002, 30 (08) : 535 - 537
  • [34] Organ tolerance following cadaveric liver transplantation for chronic graft-versus-host disease after allogeneic bone marrow transplantation
    CH Urban
    A Deutschmann
    R Kerbl
    H Lackner
    W Schwinger
    A Königsrainer
    R Margreiter
    Bone Marrow Transplantation, 2002, 30 : 535 - 537
  • [35] Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: A grading algorithm versus blinded expert panel review
    Weisdorf, DJ
    Hurd, D
    Carter, S
    Howe, C
    Jensen, LA
    Wagner, J
    Stablein, D
    Thompson, J
    Kernan, NA
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (08) : 512 - 518
  • [36] Bronchiolitis obliterans organizing pneumonia and chronic graft-versus-host disease in a child after allogeneic bone marrow transplantation
    Kleinau, I
    PerezCanto, A
    Schmid, HJ
    Grassot, A
    Staab, D
    Renz, H
    Henze, G
    Wahn, U
    Paul, K
    BONE MARROW TRANSPLANTATION, 1997, 19 (08) : 841 - 844
  • [37] Tacrolimus and methotrexate for the prophylaxis of acute graft-versus-host disease in allogeneic bone marrow transplantation in patients with hematologic malignancies
    JP Uberti
    SM Silver
    PT Adams
    P Jacobson
    A Scalzo
    V Ratanatharathorn
    Bone Marrow Transplantation, 1997, 19 : 1233 - 1238
  • [38] Cyclosporin A-induced encephalopathy after allogeneic bone marrow transplantation with prevention of graft-versus-host disease by tacrolimus
    Takahata, M
    Hashino, S
    Izumiyama, K
    Chiba, K
    Suzuki, S
    Asaka, M
    BONE MARROW TRANSPLANTATION, 2001, 28 (07) : 713 - 715
  • [39] A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation
    Haruka Nomoto
    Akiyoshi Takami
    J. Luis Espinoza
    Keitaro Matsuo
    Shohei Mizuno
    Makoto Onizuka
    Koichi Kashiwase
    Yasuo Morishima
    Takahiro Fukuda
    Yoshihisa Kodera
    Noriko Doki
    Koichi Miyamura
    Takehiko Mori
    Shinji Nakao
    Shigeki Ohtake
    Eriko Morishita
    International Journal of Hematology, 2015, 102 : 460 - 470
  • [40] EFFECTS OF BACTERIAL OROPHARYNGEAL AND NASAL COLONIZATION ON GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    LIU, KL
    HERBRECHT, R
    LIOURE, B
    JAULHAC, B
    BERGERAT, JP
    OBERLING, F
    MEDECINE ET MALADIES INFECTIEUSES, 1993, 23 (10): : 658 - 662
12345